At Radius Health, Inc, I worked as a Medical Science Liaison focused on bone health, engaging healthcare professionals and key opinion leaders on osteoporosis, fracture risk reduction, and metabolic bone disorders. I translated clinical evidence into actionable insights and supported clinical research and cross-functional medical initiatives.
At Eli Lilly & Company, I developed and reviewed scientific and promotional content across immunology, diabetes, and oncology, including work on Mirikizumab and Lebrikizumab. Earlier, I provided medical information to healthcare professionals, sales representatives, and consumers, and supported clinical research and epidemiologic studies.

